With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 30 January 2026 up to and including 5 ...

Grupa Krka zakończyła pierwsze półrocze 2025 r. z 246,7 mln euro zysku netto, co oznacza wzrost o 11 proc. rok do roku. Słoweńska spółka farmaceutyczna poprawiła również wyniki operacyjne i EBITDA.

Krka Group (LJSE:KRK) reported record first-half results for 2025 during its July 24 presentation, with sales exceeding €1 billion for the first time in a half-year period. The Slovenian ...

Visit a quote page and your recently viewed tickers will be displayed here.

As of 8:02:18 AM GMT+1. Market Open.

Krka (KRKG) has delivered a 44.51% change over the past year, with a 52-week range between 150.50 and 239.00. What Is the Average Daily Trading Volume of Krka (KRKG)? The average daily trading volume ...

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe ...

Laurus Labs has announced an investment of up to €5 million (about Rs 45 crore) in its joint venture KRKA Pharma. The investment is expected to be completed by December 31, 2025. KRKA d.d., Novo mesto ...

Visit a quote page and your recently viewed tickers will be displayed here.

About Krka d.d. KRKA dd is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following ...